T1	MajorClaim 86 216	Women with breast cancer may have an even higher risk of depression particularly in a postmenopausal or estrogen deficiency state.
T3	Premise 1280 1555	The use of fluoxetine for 6 months resulted in an improvement in quality of life, a higher completion of adjuvant treatment (chemotherapy, hormonal therapy, chemotherapy plus hormonal therapy), and a reduction in depressive symptoms compared to patients who received placebo.
T2	Claim 1556 1696	An antidepressant should be considered for early stage breast cancer patients with depressive symptoms who are receiving adjuvant treatment.
R1	Support Arg1:T3 Arg2:T2	
